Latest News & Updates

Breaking News

  • 51 minutes ago

  • Team Pharma Now

ELMACH Highlights WKH-100 Intermittent Cartoner for Pharmaceutical and Cosmetic Packaging
Breaking News
HUTCHMED Starts Phase III Trial In China Testing Four-Drug Combo For Metastatic Pancreatic Cancer After First Patient Dosed On Dec 30, 2025

Simantini Singh Deo

Other trending news you may like to read

ELMACH Highlights WKH-100 Intermittent Cartoner for Pharmaceutical and Cosmetic Packaging

ELMACH’s WKH-100 horizontal cartoner delivers servo-driven precision, modular design, and versatile cartoning for regulated industries.

Team Pharma Now

Pharma Now

HUTCHMED Starts Phase III Trial In China Testing Four-Drug Combo For Metastatic Pancreatic Cancer After First Patient Dosed On Dec 30, 2025

HUTCHMED initiates Phase III enrollment in China for a four-drug combination study targeting first-line metastatic pancreatic cancer.

Simantini Singh Deo

Pharma Now

Genelux Strengthens Leadership With Appointment Of Dr. Jason Litten As CMO To Advance Late-Stage Trials Of Olvi-Vec

Genelux appoints oncology veteran Jason Litten as CMO to guide clinical strategy for its lead immunotherapy candidate Olvi-Vec.

Simantini Singh Deo

Pharma Now

Theriva Biologics Gets Positive EMA Scientific Advice For Phase 3 Trial Design Of VCN-01 In Metastatic Pancreatic Ductal Adenocarcinoma

Theriva secures EMA CHMP guidance endorsing a Phase 3 study of VCN-01 with chemotherapy for metastatic PDAC.

Simantini Singh Deo

Pharma Now